Ali Al-Husry

Ali Al-Husry discloses dealings in Hikma Pharmaceuticals PLC to RNS (LSE). Over a trading history stretching from 30 April 2025 to 19 December 2025, the count stands at 4 filings.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 19 December 2025 came the latest disclosure, a share grant in Hikma Pharmaceuticals PLC. Typically, a trade is published a median of 2 days after it takes place. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.